Literature DB >> 25616651

Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours.

Dorte Glintborg1, Magda L Altinok1, Kresten R Petersen2, Pernille Ravn2.   

Abstract

Hirsutism is present in up to 25% reproductive aged women and is most often caused by polycystic ovary syndrome. Less than 5% of patients with hirsutism are diagnosed with rare endocrine diseases including ovarian or adrenal androgen-producing tumours, but these tumours may be malignant and need surgery. Terminal hair growth on lip and chin gradually increases after menopause, which complicates distinction from normal physiological variation. Precise testosterone assays have just recently become available in the daily clinic. We present three women diagnosed with testosterone-producing tumours. Gold standard techniques were used to measure testosterone levels. All tumours originated from the ovaries. Based on the present cases and the existing literature, we suggest that androgen-producing tumours should be suspected in patients with rapid progression of hyperandrogen symptoms, particularly when total testosterone levels are above three times the upper reference limit. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25616651      PMCID: PMC4307073          DOI: 10.1136/bcr-2014-204797

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  39 in total

Review 1.  Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.

Authors:  H F Escobar-Morreale; E Carmina; D Dewailly; A Gambineri; F Kelestimur; P Moghetti; M Pugeat; J Qiao; C N Wijeyaratne; S F Witchel; R J Norman
Journal:  Hum Reprod Update       Date:  2011-11-06       Impact factor: 15.610

Review 2.  The hair follicle as an estrogen target and source.

Authors:  Ulrich Ohnemus; Murat Uenalan; José Inzunza; Jan-Ake Gustafsson; Ralf Paus
Journal:  Endocr Rev       Date:  2006-07-28       Impact factor: 19.871

3.  Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.

Authors:  Gwenaelle Abiven; Joel Coste; Lionel Groussin; Philippe Anract; Frédérique Tissier; Paul Legmann; Bertrand Dousset; Xavier Bertagna; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2006-05-02       Impact factor: 5.958

4.  Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.

Authors:  Sandra Karrer-Voegeli; François Rey; Marianne J Reymond; Jean-Yves Meuwly; Rolf C Gaillard; Fulgencio Gomez
Journal:  Medicine (Baltimore)       Date:  2009-01       Impact factor: 1.889

5.  Adrenal androgen excess in hyperandrogenism: relation to age and body mass.

Authors:  C Morán; E Knochenhauer; L R Boots; R Azziz
Journal:  Fertil Steril       Date:  1999-04       Impact factor: 7.329

6.  Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods.

Authors:  Karen K Miller; William Rosner; Hang Lee; Joan Hier; Gemma Sesmilo; David Schoenfeld; Gregory Neubauer; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

7.  Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Authors:  T J Cawood; P J Hunt; D O'Shea; D Cole; S Soule
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

8.  Combined adrenal and ovarian venous sampling to localize an androgen producing tumor.

Authors:  Monica D Agarwal; Scott O Trerotola
Journal:  Cardiovasc Intervent Radiol       Date:  2009-08-18       Impact factor: 2.740

Review 9.  Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review.

Authors:  G L Jones; J M Hall; A H Balen; W L Ledger
Journal:  Hum Reprod Update       Date:  2007-09-28       Impact factor: 15.610

Review 10.  Selective venous sampling for androgen-producing ovarian pathology.

Authors:  Eric D Levens; Brian W Whitcomb; John M Csokmay; Lynnette K Nieman
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-21       Impact factor: 3.478

View more
  2 in total

1.  MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).

Authors:  A A Gheorghisan-Galateanu; D Terzea; A Valea; M Carsote
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

2.  Virilization of a postmenopausal woman by a mucinous cystoadenoma.

Authors:  Sara Alonso Díaz; Belén Vega Piñero; Lía Nattero Chávez; Ignacio Pinilla Pagnon; Andrés Ortiz-Flores; Manuel Luque-Ramírez
Journal:  Oxf Med Case Reports       Date:  2018-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.